drugset / Trial / NCT03448159

Summary

The FLOW trial is a randomized placebo-controlled trial analyzing the effect of coupling an anti-depressant, fluoxetine (Prozac), and exercise to improve motor recovery following a stroke.

Timeline

Start
2019-01-01
Primary completion
2022-09-30
Completion
2022-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule 20 mg